Unveiling cutting-edge advances in CAR-T cell therapy for lymphoma
Peer-Reviewed Publication
Welcome to theTsinghua University Press (TUP) News Page.
Below are the latest research news from TUP.
Updates every hour. Last Updated: 20-Dec-2025 07:11 ET (20-Dec-2025 12:11 GMT/UTC)
A groundbreaking new review comprehensively synthesizes the latest developments in next-generation chimeric antigen receptor T cell (CAR-T) therapies, highlighting key preclinical and clinical breakthroughs in the treatment of lymphoma. The article examines barriers to CAR-T efficacy and provides an in-depth analysis of innovative strategies, including multi-specific CAR, T cells redirected for universal cytokine-mediated killing (TRUCKs), switch receptor CAR, safety switch/suicide system, and in vivo CAR-T cells. With a special focus on the role of epigenetics and metabolism in CAR-T cell exhaustion, the review offers valuable insights and future directions for advancing CAR-T immunotherapy.
Bispecific antibodies (bsAbs) refer to antibodies that bind two different antigens or epitopes simultaneously, which can enhance the targeting of antibodies and the efficacy of cancer treatments. Recent studies indicate that bsAb is a promising first-line or later-line treatment for non-small cell lung cancer (NSCLC) patients and may overcome treatment resistance. This study explores the classification, mechanisms of action and clinical application of bsAbs in the treatment of NSCLC.
Perovskite-structured BaFe0.4Co0.4Zr0.1Y0.1O3-δ (BFCZY) exhibits proton-electron-oxygen ion triple conductions and high catalytic activity of oxygen reduction (ORR) and oxygen evolution reaction (OER) at low temperatures. Although it has stability problems in a humid air environment, the degradation mechanism of BFCZY and the influences of temperature, steam content and polarization on its stability have been rarely studied. The activity and stability of the BFCZY oxygen electrode are significantly improved through heterointerface engineering by infiltrating the BaCoO3 (BCO) catalyst. It is imperative to fill this research gap, as it is crucial for promoting the commercial development of reversible protonic ceramic electrochemical cells (R-PCECs).
Highly efficient chemiresistive gas sensors are crucial for numerous applications. Notably, though the generally high working temperature brings fine sensing performance, as well as causing high power consumption, poor safety, and disabled operational stability. Thanks to the cost-effective, simplified structure and integrated diversity, room temperature (RT) operational mode has been put forward and applied in gas sensor devices. However, insufficient limits of detection limit (LOD) and disappointingly long detection time limit their broad applications, meanwhile, the existing sensing mechanism based on the charge transfer between the analyte gas and the oxide surface hampers room temperature gas sensing with low LOD and rapid speed.
Clinical photothermal therapy continues to encounter significant challenges, including systemic toxicity risks associated with intravenous drug administration and inadequate photothermal specificity in the targeted lesion area, particularly concerning the prevention of bone tumor recurrence. To address these issues, this study developed a photothermal functional composite bioceramic scaffold that integrates a Si3N4 matrix known for its excellent antibacterial properties, black glass SiOC exhibiting photothermal characteristics, and bone-inductive graphene oxide (GO). A mapping model was established to correlate the properties of the GO/KH570-H/Si3N4 precursor slurry with the parameters of the SLA additive manufacturing process. Following sintering at 1300 ℃, a GO/SiOC/Si3N4 composite ceramic was successfully obtained. Under irradiation with 808 nm near-infrared light at an intensity of 1 W/cm², the temperature of the leather-coated composite scaffold reached 47.8 ℃ within 10 minutes. This innovative approach presents a promising solution for precise photothermal therapy in postoperative bone tumor repair.